A Study of SHR-2173 in Participants With Systemic Lupus Erythematosus

Clinical trial NCT07299422 · RECRUITING

Trial details

NCT number: NCT07299422
Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2026-04-03
Primary completion: 2028-03-01
Enrollment: 248

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.